Consistently, Hawila et al. (5) found that CCR5 regulates the immunosuppressive effect of MDSC at tumor sites by enhancing the production of Arg I. Arginine is important for maintain the activity of T-cell through expression T-cell coreceptor CD3ζ, while Arg I can degrade arginine. Here, CD8A is linked to neoplasm.